% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Caers:119720,
author = {J. Caers and N. Withofs and J. Hillengass$^*$ and P. Simoni
and E. Zamagni and R. Hustinx and Y. Beguin},
title = {{T}he role of positron emission tomography-computed
tomography and magnetic resonance imaging in diagnosis and
follow up of multiple myeloma.},
journal = {Haematologica},
volume = {99},
number = {4},
issn = {1592-8721},
address = {Pavia},
publisher = {Ferrata Storti Foundation},
reportid = {DKFZ-2017-00347},
pages = {629 - 637},
year = {2014},
abstract = {Multiple myeloma is the second most common hematologic
malignancy and occurs most commonly in elderly patients.
Almost all multiple myeloma patients develop bone lesions in
the course of their disease or have evidence of bone loss at
initial diagnosis. Whole-body conventional radiography
remains the gold standard in the diagnostic evaluation, but
computed tomography, magnetic resonance imaging and
18F-fluorodeoxyglucose positron emission tomography are
increasingly used as complementary techniques in the
detection of bone lesions. Moreover, the number of lesions
detected and the presence of extramedullary disease give
strong prognostic information. These new techniques may help
to assess treatment response in solitary plasmacytoma or in
multiple myeloma. In this article, we review recent data on
the different imaging techniques used at diagnosis and in
the assessment of treatment response, and discuss some
current issues.},
cin = {E013},
ddc = {610},
cid = {I:(DE-He78)E013-20160331},
pnm = {315 - Imaging and radiooncology (POF3-315)},
pid = {G:(DE-HGF)POF3-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:24688111},
pmc = {pmc:PMC3971072},
doi = {10.3324/haematol.2013.091918},
url = {https://inrepo02.dkfz.de/record/119720},
}